Shouxiangu(SH:603896) Shang Hai Zheng Quan Bao·2025-10-28 21:08Core Viewpoint - The company, Zhejiang Shouxiangu Pharmaceutical Co., Ltd., has released its quarterly report, ensuring the accuracy and completeness of the financial information presented [2][3]. Financial Data Summary - The third-quarter financial statements have not been audited [3]. - The report includes major accounting data and financial indicators, with the reporting period defined as the three months from the beginning to the end of the quarter [3]. - A retrospective adjustment has been made due to a business combination with a subsidiary, impacting the financial data for the previous year [4]. Non-Recurring Gains and Losses - The company has identified significant non-recurring gains and losses, which are detailed in the report [5]. Shareholder Information - The report includes information on the total number of ordinary shareholders and the top ten shareholders, although there are no changes reported in the shareholding structure due to securities lending activities [7]. Financial Statements - The consolidated balance sheet and profit and loss statement for the period from January to September 2025 have been prepared, with the audit type noted as unaudited [9]. - The net profit of the acquired entity prior to the merger was reported as 63,703.61 yuan, while the previous year's net profit was -701,132.81 yuan [9].